Working together to reduce the global burden of kidney cancer

Kidney cancer is a global issue. Every year, 431,000 people worldwide will be diagnosed with kidney cancer.

Click here for shareable information, graphics and materials about kidney cancer for patient organisations worldwide.

Highlights from the ESMO Virtual Congress 2021

The European Society of Medical Oncology (ESMO) congress was held virtually from 16-21 September 2021. The presentations are available to view on the ESMO website if you have previously logged in to the site. The International Kidney Cancer Coalition (IKCC) attended the virtual scientific programme to keep abreast of the latest advances in the care and treatment of people with kidney cancer.

Read more

2021 Global Kidney Cancer Summit

The 11th annual Global Kidney Cancer Summit took place virtually in September 2021. A huge thank you to everyone who came to build and strengthen connections.
Over the two-day event, we learnt from each other, shared our successes and challenges and collectively built capacity across the kidney cancer network.

Read more

Save the Date: World Kidney Cancer Day 2022

Save the date for the 6th World Kidney Cancer Day on 16 June 2022. Join patients, families, friends, carers, healthcare professionals, researchers and local kidney cancer organisations from around the world coming together to raise awareness of clinical trials and access to treatment. Start conversations about how clinical trials can improve access to new treatments for kidney cancer. To improve the lives of kidney cancer patients worldwide ‘We need to talk’.

Read more

Updates from IKCC

1 week ago
"Handling the Holidays with Cancer: Creating a New Normal for the Holiday Season"

FREE, interactive webinar for patients & caregivers. Ask questions and learn from experts!

Register: https://t.co/2MlJR1pPaI

Docs, invite your patients!
Printable flyer: https://t.co/fC0p9KGLkO https://t.co/7HEKkmRADF
1 week ago
In America, the FDA approves pembrolizumab for adjuvant treatment of intermediate-high/high risk of recurrence following nephrectomy, or following nephrectomy + resection of metastases. 1st adjuvant immunotherapy for #kidneycancer https://t.co/iBuaYjaNOM
2 weeks ago
Action needed as the UK Parliamentary probe finds racism evidence in NHS sickle cell care which can affect black kidney cancer patients https://t.co/IwV5xbL5xB via @pharmaphorum
2 weeks ago
Call for Patient Poster Abstracts #EAU22

Just a few weeks left to submit your abstract! Contribute to Europe’s largest annual #urology congress. Deadline: 1 December 2021. https://t.co/YnsXWxNxcl
2 weeks ago
Just in @KCA_Journal 👉A rapid review+ meta-analysis of 1st line ImmunoRx combinations in metastatic #kidneycancer by @JShpil26 @BIDMCUrology #DavidMcDermott Will be very helpful in discussion with a newly diagnosed patient👇 https://t.co/OtCZqogRDH @OncoAlert @urotoday https://t.co/iGLhyqBKKp

Did you know?

Kidney cancer is often found by accident.

Kidney cancer is the 12th most prevalent cancer worldwide.

About 59 per cent of kidney cancer cases occur in more developed countries.

Our Global Network

IKCC welcomes every organisation that has an interest in kidney cancer and who pledges to conform to our Code of Conduct. We extend an open invitation to become part of this international network.

Explore Our Global Network

Join our mailing list

In the newsletter we highlight news about kidney cancer diagnosis and treatment, and other relevant discussions.

Sign up